PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Virus & Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR3569, Paris 75015, France.\', \'Sorbonne Paris Cité, Université de Paris, Paris 75013, France.\', \'Emerging Diseases Epidemiology Unit, Department of Global Health, Institut Pasteur, Paris 75015, France.\', \'Pasteur-TheraVectys joint unit, Institut Pasteur, Paris 75015, France.\', \'Malaria: Parasites and Hosts Unit, Department of Parasites and Insect Vectors, Institut Pasteur, Paris 75015, France.\', \'Vaccine Research Institute, Faculté de Médecine, INSERM U955, Université Paris-Est Créteil, Créteil 94028, France.\', \'Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, INSERM U1222, Paris 75015, France.\', \'Investigation Clinique et Accès aux Ressources Biologiques (ICAReB), Center for Translational Research, Institut Pasteur, Paris 75015, France.\', \'Molecular Virology and Vaccinology Unit, Department of Virology, Institut Pasteur, Paris 75015, France.\', \'Direction de la Recherche Médicale, Institut Pasteur, Paris 75015, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1016/j.xcrm.2021.100275
?:hasPublicationType
?:journal
  • Cell reports. Medicine
is ?:pmid of
?:pmid
?:pmid
  • 33899033
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all